MDR-TB

11.

The Global Fund forms partnership to find missing cases of TB

17 Oct 2017
The countries involved account for 55% of all missed cases of TB and multidrug-resistant TB

The Global Fund, the World Health Organization (WHO), the Stop TB Partnership and 13 countries with a high burden of TB have launched a program to find and treat an additional 1.5 million missing cases of TB by the end of 2019.

2.

Advancing the fight against TB with the expertise of the Global Fund Advocates Network

16 May 2017
The goal is to build political momentum ahead of next year’s U.N. High-Level Meeting on TB

Working through the Global Fund Advocates Network (GFAN), tuberculosis (TB) advocates are looking to strategically advance efforts to combat the disease and take advantage of several key international meetings over the coming 15 months.

5.

More global attention for tuberculosis, including increased funding to find missing patients

16 Jan 2017
Through its catalytic investments, the Global Fund is pushing $125 million into TB case finding

Two high-profile initiatives were launched late last year, each designed to shore up the response to the global tuberculosis epidemic.

6.

New WHO recommendations for MDR-TB will lower the cost of treatment and improve outcomes

13 May 2016
New regimen will generate savings for The Global Fund

The World Health Organization has issued new recommendations for the treatment of multi-drug-resistant TB, involving the use of a regimen that is shorter and cheaper compared to what is currently being used.

1.

What The Global Fund replenishment means to people on the ground – a personal story

2 Mar 2016
GFO speaks with Louie Zepeda-Teng

In this fast-paced world, it is easy sometimes to forget the individual stories of those affected by the three diseases. These personal stories resonate with all of us as global citizens. They are critical in highlighting the significance of the work of Global Fund–supported programs, bringing true meaning and value to the $13 billion replenishment target.

4.

First Shipment of Drugs to Treat MDR-TB in Somalia Expected to Arrive Soon, PR Says

9 Jul 2013
Somalia to start managing MDR-TB
Global Fund’s investments are channelled through World Vision

Somalia has a major burden of multi-drug-resistant TB (MDR-TB), rivalling that of the most-affected countries in Asia. According to World Vision International Somalia (WVI-S), principal recipient (PR) for the Global Fund’s TB grants in Somalia, the first shipment of medicines to treat MDR-TB is expected to arrive this month.

8.

Opportunity for Scale-Up in Next Implementation Period of Nepal TB Grant

11 Apr 2013
Funding of $15.1 million approved
Responsibility for procurement of health products shifts to global mechanisms, but the long-term plan is to build procurement capacity in Nepal

The Grants Renewal Panel says that overall performance of a single-stream-of-funding TB grant in Nepal has been high and that there is an opportunity for scale-up in the next implementation period.

7.

Significant Declines in TB Incidence, Prevalence and Mortality, but MDR-TB Remains a Threat

9 Apr 2013

TB mortality has decreased significantly since 2000 and treatment success rates have shown steady improvement. More than half of the countries that have received Global Fund support are on track to meet the international targets for case detection, treatment success, and TB disease incidence. However, multi-drug-resistant TB (MDR-TB) remains a critical threat.

Subscribe to MDR-TB